Sign in
4/A

Changes in Ownership

Dogwood Therapeutics, Inc. Filed Acc 0001415889-23-002583

Options or other derivatives

  • CHIEF EXECUTIVE OFFICER acquired 410,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Duncan Gregory Scott CHIEF EXECUTIVE OFFICER 2022-12-12 Grant or award · Stock Option (right to buy) +410,000 410,000 D
Loading xslF345X03/form4a-02152023_050206.xml…